Injectable Drug Compatibility News

New IV drug compatibility and stability data added to King Guide in our Winter 2024 update.

The Fall 2024 update is the 233rd quarterly update to King Guide to Parenteral Admixtures. Our 2024 edition of King Guide provides separate entries for over 600 parenteral drugs either online or in our four-volume, 2000+ page reference. New monograph:ANGIOTENSIN II New Stability Information:BEVACIZUMAB New Compatibility Information:FLUCONAZOLE, MANNITOL, MOXIFLOXACIN HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, TOTAL PARENTERAL NUTRITION SOLUTIONS, and SILDENAFIL CITRATE with 43 other drugs. View past updates...

We are pleased to announce the launch of our new 2024 Y-Site Compatibility Wall Charts. Ideal for situations where a quick 'yes' or 'no answer is required prior to administration of intravenous drugs.You can easily check if two drugs can be mixed in the same infusion line (Y-site) without causing precipitation, degradation, or inactivation. You can also see which infusion fluids are compatible with each drug, and if there are any FDA Boxed Warning Drugs that require special attention. Updated for 2024 with the latest information from the King Guide to Parenteral Admixtures, a trusted source of intravenous drug compatibility...

In this update to the King Guide to Parenteral Admixtures we added a new monograph for SULBACTAM AND DURLOBACTAM. We also added new stability information to the monographs for OMADACYCLINE. New compatibility information was added for SULBACTAM AND DURLOBACTAM in combination with 95 different drugs.

In this update we added a new monograph for NUTRILIPID. We also added new stability information to the monographs for FAT EMULSION, NUTRILIPID, NOREPINEPHRINE BITARTRATE and TRACE ELEMENT SOLUTION. New compatibility information was added to the existing drug monographs for FAT EMULSION with 36 different drugs; INTRALIPID, NUTRILIPID, and SMOFLIPID, each with 17 different drugs; TOTAL PARENTERAL NUTRITION SOLUTIONS, TRACE ELEMENT SOLUTION, and VALPROATE SODIUM.